ArticleJBMR plus2026

BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva.

Haitao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.